Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Revenue: 2009-2024

Historic Revenue for Gyre Therapeutics (GYRE) over the last 16 years, with Dec 2024 value amounting to $105.8 million.

  • Gyre Therapeutics' Revenue rose 19.92% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.3 million, marking a year-over-year increase of 2.13%. This contributed to the annual value of $105.8 million for FY2024, which is 6.78% down from last year.
  • Per Gyre Therapeutics' latest filing, its Revenue stood at $105.8 million for FY2024, which was down 6.78% from $113.5 million recorded in FY2023.
  • In the past 5 years, Gyre Therapeutics' Revenue ranged from a high of $113.5 million in FY2023 and a low of $7.3 million during FY2021.
  • Moreover, its 3-year median value for Revenue was $105.8 million (2024), whereas its average is $107.2 million.
  • In the last 5 years, Gyre Therapeutics' Revenue soared by 299,357.14% in 2020 and then crashed by 64.97% in 2021.
  • Over the past 5 years, Gyre Therapeutics' Revenue (Yearly) stood at $20.9 million in 2020, then tumbled by 64.97% to $7.3 million in 2021, then skyrocketed by 1,293.98% to $102.3 million in 2022, then grew by 10.91% to $113.5 million in 2023, then declined by 6.78% to $105.8 million in 2024.